<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05024292</url>
  </required_header>
  <id_info>
    <org_study_id>2021MT</org_study_id>
    <nct_id>NCT05024292</nct_id>
  </id_info>
  <brief_title>Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment</brief_title>
  <acronym>ORANGE</acronym>
  <official_title>Oriental Research Alliance of Acute Ischemic Stroke Given Endovascular Treatment:A Multicenter Registry Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jinshan Branch of Shanghai Sixth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Fifth People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First people's Hospital of Kunshan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhejiang Huzhou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For patients with acute ischemic stroke (AIS) with anterior circulation proximal large vessel&#xD;
      occlusion (LVO), mechanical thrombectomy (MT) reduces disability in patients when it is&#xD;
      performed within 6 h of the time the patients with a stroke were last known to be healthy and&#xD;
      up to 24 h after stroke onset in patients selected using brain perfusion imaging. For&#xD;
      patients with acute ischemic stroke (AIS) with posterior circulation large vessel occlusion,&#xD;
      MT could be benefit the patients when performed within 24 hours since onset. This is a&#xD;
      multicenter registration study of the AIS-LVO treated with endovascular intervention under&#xD;
      the guideline. This study will record the patients' demographic and clinical data, image&#xD;
      data, procedure of neurointervention and outcomes in 3 months. Samples of thrombus and serum&#xD;
      will be collected and stored for later analysis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">April 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Modified rankin scale (mRS) at 3 month following</measure>
    <time_frame>3 month</time_frame>
    <description>mRS 0-2 is defined as good outcome, mRS 3-6 is defined as bad outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mRS at 3 month following</measure>
    <time_frame>3 month</time_frame>
    <description>mRS 0-1 is defined as excellent outcome, mRS 3-6 is defined as non excellent outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality following 1 month</measure>
    <time_frame>1 month</time_frame>
    <description>Mortality of 1 month after stoke onset</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic intracerebral hemorrhage (sICH) after procedure</measure>
    <time_frame>period in hospital</time_frame>
    <description>Symptomatic intracerebral hemorrhage</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Anterior circulation cerebral infarction</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Posterior circulation cerebral infarction</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      thrombus retrieved from the occluded artery. Serum collected from the vein at different time&#xD;
      points.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Confirmed AIS of the anterior circulation; patients within 4.5 h of hospital onset, IV tPA&#xD;
        (0.9 mg/kg weight, Boehringer Ingelheim, Germany) was administered after excluding the&#xD;
        contraindications, which was bridged with endovascular therapy if LVO was confirmed. For&#xD;
        patients with anterior LVO between 4.5 h and 6 h of hospital admission, direct MT was&#xD;
        performed after non-contrast computed tomography (CT) scan and CT angiography. For patients&#xD;
        with anterior LVO between 6 h and 24 h of hospital onset, MT was performed after&#xD;
        multi-model CT evaluation according to the guideline.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 - 95.&#xD;
&#xD;
          2. Clinical signs consistent with acute ischemic stroke.&#xD;
&#xD;
          3. Prestroke Modified Rankin Score ≤ 2&#xD;
&#xD;
          4. Consent obtained within 24 hours from last known well.&#xD;
&#xD;
          5. Thrombolysis in Cerebral Infarction (TICI) 0-1 flow in The M1 or M2 segment of the&#xD;
             middle cerebral artery (MCA), A1 or A2 segment of the anterior cerebral artery (ACA),&#xD;
             or carotid terminus confirmed by CT or MR angiography; or the vertebral artery,&#xD;
             basilar artery, posterior cerebral artery.&#xD;
&#xD;
          6. For patients with anterior LVO within 6 to 16 hours of last known normal, the imaging&#xD;
             criteria to meet: ischemic core less than 70 ml,mismatch ratio of 1.8 or more, and a&#xD;
             penumbra of 15 ml or more. For patients with anterior LVO within 6 to 24 hours of last&#xD;
             known normal, following criteria: age ≥80 years，NIHSS≥10，infarct volume of less than&#xD;
             21 ml；age ≤80 years，NIHSS≥10，infarct volume of less than 31 ml；age ≤80&#xD;
             years，NIHSS≥20，infarct volume of less than 51 ml.&#xD;
&#xD;
             For patients with posterior LVO, time of onset to admission is within 24 hours.&#xD;
&#xD;
          7. Subject is willing to conduct protocol-required follow-up visits.&#xD;
&#xD;
          8. Subject or subject's legally authorized representative has signed and dated an&#xD;
             Informed consent Form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Female who is pregnant.&#xD;
&#xD;
          2. Serious sensitivity to radiographic contrast agents.&#xD;
&#xD;
          3. Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of hemorrhage on&#xD;
             presentation.&#xD;
&#xD;
          4. Warfarin therapy with international normalized ratio(INR) greater than 1.7.&#xD;
&#xD;
          5. Low molecular Weight Heparins, Heparin, Factor Xa inhibitors or direct thrombin&#xD;
             inhibitors as full dose within the last 48 hours.&#xD;
&#xD;
          6. Baseline lab values: glucose &lt;50 mg/dL or &gt; 400 mg/dL, platelets &lt; 100,000&#xD;
&#xD;
          7. Life expectancy of less than 90 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 22, 2021</study_first_submitted>
  <study_first_submitted_qc>August 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 27, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Jiao Tong University Affiliated Sixth People's Hospital</investigator_affiliation>
    <investigator_full_name>Yueqi Zhu</investigator_full_name>
    <investigator_title>Associated dean of the radiology</investigator_title>
  </responsible_party>
  <keyword>acute ischemic stroke</keyword>
  <keyword>thrombectomy</keyword>
  <keyword>thrombolysis</keyword>
  <keyword>outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

